Print

Medtronic, Inc. (MDT) Advances Research on Peripheral Devices, Highlights Upcoming Presentations  
5/16/2011 10:09:57 AM

MINNEAPOLIS--(BUSINESS WIRE)--A global leader in advancing the treatment of cardiovascular disease through innovative medical technology, Medtronic, Inc. (NYSE: MDT) today announced recent milestones in its clinical program for the IN.PACT drug-eluting balloon (DEB) technology.
//-->